Cargando…
Programmable Unlocking Nano‐Matryoshka‐CRISPR Precisely Reverses Immunosuppression to Unleash Cascade Amplified Adaptive Immune Response
Immune checkpoint blockade (ICB) is an attractive option in cancer therapy, but its efficacy is still less than expected due to the transient and incomplete blocking and the low responsiveness. Herein, an unprecedented programmable unlocking nano‐matryoshka‐CRISPR system (PUN) targeting programmed c...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8261501/ https://www.ncbi.nlm.nih.gov/pubmed/34258164 http://dx.doi.org/10.1002/advs.202100292 |
_version_ | 1783719025611636736 |
---|---|
author | Yang, Jin Li, Zhike Shen, Meiling Wang, Yan Wang, Li Li, Jiamiao Yang, Wen Li, Jie Li, Haijun Wang, Xinxin Wu, Qinjie Gong, Changyang |
author_facet | Yang, Jin Li, Zhike Shen, Meiling Wang, Yan Wang, Li Li, Jiamiao Yang, Wen Li, Jie Li, Haijun Wang, Xinxin Wu, Qinjie Gong, Changyang |
author_sort | Yang, Jin |
collection | PubMed |
description | Immune checkpoint blockade (ICB) is an attractive option in cancer therapy, but its efficacy is still less than expected due to the transient and incomplete blocking and the low responsiveness. Herein, an unprecedented programmable unlocking nano‐matryoshka‐CRISPR system (PUN) targeting programmed cell death ligand 1 (PD‐L1) and protein tyrosine phosphatase N2 (PTPN2) is fabricated for permanent and complete and highly responsive immunotherapy. While PUN is inert at normal physiological conditions, enzyme‐abundant tumor microenvironment and preternatural intracellular oxidative stress sequentially trigger programmable unlocking of PUN to realize a nano‐matryoshka‐like release of CRISPR/Cas9. The successful nucleus localization of CRISPR/Cas9 ensures the highly efficient disruption of PD‐L1 and PTPN2 to unleash cascade amplified adaptive immune response via revoking the immune checkpoint effect. PD‐L1 downregulation in tumor cells not only disrupts PD‐1/PD‐L1 interaction to attenuate the immunosurveillance evasion but also spurs potent immune T cell responses to enhance adaptive immunity. Synchronously, inhibition of JAK/STAT pathway is relieved by deleting PTPN2, which promotes tumor susceptibility to CD8(+) T cells depending on IFN‐γ, thus further amplifying adaptive immune responses. Combining these advances together, PUN exhibits optimal antitumor efficiency and long‐term immune memory with negligible toxicity, which provides a promising alternative to current ICB therapy. |
format | Online Article Text |
id | pubmed-8261501 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-82615012021-07-12 Programmable Unlocking Nano‐Matryoshka‐CRISPR Precisely Reverses Immunosuppression to Unleash Cascade Amplified Adaptive Immune Response Yang, Jin Li, Zhike Shen, Meiling Wang, Yan Wang, Li Li, Jiamiao Yang, Wen Li, Jie Li, Haijun Wang, Xinxin Wu, Qinjie Gong, Changyang Adv Sci (Weinh) Research Articles Immune checkpoint blockade (ICB) is an attractive option in cancer therapy, but its efficacy is still less than expected due to the transient and incomplete blocking and the low responsiveness. Herein, an unprecedented programmable unlocking nano‐matryoshka‐CRISPR system (PUN) targeting programmed cell death ligand 1 (PD‐L1) and protein tyrosine phosphatase N2 (PTPN2) is fabricated for permanent and complete and highly responsive immunotherapy. While PUN is inert at normal physiological conditions, enzyme‐abundant tumor microenvironment and preternatural intracellular oxidative stress sequentially trigger programmable unlocking of PUN to realize a nano‐matryoshka‐like release of CRISPR/Cas9. The successful nucleus localization of CRISPR/Cas9 ensures the highly efficient disruption of PD‐L1 and PTPN2 to unleash cascade amplified adaptive immune response via revoking the immune checkpoint effect. PD‐L1 downregulation in tumor cells not only disrupts PD‐1/PD‐L1 interaction to attenuate the immunosurveillance evasion but also spurs potent immune T cell responses to enhance adaptive immunity. Synchronously, inhibition of JAK/STAT pathway is relieved by deleting PTPN2, which promotes tumor susceptibility to CD8(+) T cells depending on IFN‐γ, thus further amplifying adaptive immune responses. Combining these advances together, PUN exhibits optimal antitumor efficiency and long‐term immune memory with negligible toxicity, which provides a promising alternative to current ICB therapy. John Wiley and Sons Inc. 2021-05-14 /pmc/articles/PMC8261501/ /pubmed/34258164 http://dx.doi.org/10.1002/advs.202100292 Text en © 2021 The Authors. Advanced Science published by Wiley‐VCH GmbH https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Articles Yang, Jin Li, Zhike Shen, Meiling Wang, Yan Wang, Li Li, Jiamiao Yang, Wen Li, Jie Li, Haijun Wang, Xinxin Wu, Qinjie Gong, Changyang Programmable Unlocking Nano‐Matryoshka‐CRISPR Precisely Reverses Immunosuppression to Unleash Cascade Amplified Adaptive Immune Response |
title | Programmable Unlocking Nano‐Matryoshka‐CRISPR Precisely Reverses Immunosuppression to Unleash Cascade Amplified Adaptive Immune Response |
title_full | Programmable Unlocking Nano‐Matryoshka‐CRISPR Precisely Reverses Immunosuppression to Unleash Cascade Amplified Adaptive Immune Response |
title_fullStr | Programmable Unlocking Nano‐Matryoshka‐CRISPR Precisely Reverses Immunosuppression to Unleash Cascade Amplified Adaptive Immune Response |
title_full_unstemmed | Programmable Unlocking Nano‐Matryoshka‐CRISPR Precisely Reverses Immunosuppression to Unleash Cascade Amplified Adaptive Immune Response |
title_short | Programmable Unlocking Nano‐Matryoshka‐CRISPR Precisely Reverses Immunosuppression to Unleash Cascade Amplified Adaptive Immune Response |
title_sort | programmable unlocking nano‐matryoshka‐crispr precisely reverses immunosuppression to unleash cascade amplified adaptive immune response |
topic | Research Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8261501/ https://www.ncbi.nlm.nih.gov/pubmed/34258164 http://dx.doi.org/10.1002/advs.202100292 |
work_keys_str_mv | AT yangjin programmableunlockingnanomatryoshkacrisprpreciselyreversesimmunosuppressiontounleashcascadeamplifiedadaptiveimmuneresponse AT lizhike programmableunlockingnanomatryoshkacrisprpreciselyreversesimmunosuppressiontounleashcascadeamplifiedadaptiveimmuneresponse AT shenmeiling programmableunlockingnanomatryoshkacrisprpreciselyreversesimmunosuppressiontounleashcascadeamplifiedadaptiveimmuneresponse AT wangyan programmableunlockingnanomatryoshkacrisprpreciselyreversesimmunosuppressiontounleashcascadeamplifiedadaptiveimmuneresponse AT wangli programmableunlockingnanomatryoshkacrisprpreciselyreversesimmunosuppressiontounleashcascadeamplifiedadaptiveimmuneresponse AT lijiamiao programmableunlockingnanomatryoshkacrisprpreciselyreversesimmunosuppressiontounleashcascadeamplifiedadaptiveimmuneresponse AT yangwen programmableunlockingnanomatryoshkacrisprpreciselyreversesimmunosuppressiontounleashcascadeamplifiedadaptiveimmuneresponse AT lijie programmableunlockingnanomatryoshkacrisprpreciselyreversesimmunosuppressiontounleashcascadeamplifiedadaptiveimmuneresponse AT lihaijun programmableunlockingnanomatryoshkacrisprpreciselyreversesimmunosuppressiontounleashcascadeamplifiedadaptiveimmuneresponse AT wangxinxin programmableunlockingnanomatryoshkacrisprpreciselyreversesimmunosuppressiontounleashcascadeamplifiedadaptiveimmuneresponse AT wuqinjie programmableunlockingnanomatryoshkacrisprpreciselyreversesimmunosuppressiontounleashcascadeamplifiedadaptiveimmuneresponse AT gongchangyang programmableunlockingnanomatryoshkacrisprpreciselyreversesimmunosuppressiontounleashcascadeamplifiedadaptiveimmuneresponse |